CJC-1295 No DAC + Ipamorelin — Lyophilized Peptide Blend
This research blend combines CJC-1295 No DAC (Modified GRF 1-29), a short-acting growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS-R1a / ghrelin-receptor agonist). The two are frequently studied together as a complementary GHRH + GHRP model for stimulating pulsatile growth hormone (GH) release in research settings. For laboratory research use only — not for human or veterinary use.
Research Applications
- GHRH + GHRP synergy and pulsatile GH-release research
- GHS-R1a (ghrelin receptor) signaling studies
- Pituitary GH-secretion and endocrine pathway models
For background, see our CJC-1295 research guide, the standalone CJC-1295 No DAC (5mg), and CJC-1295 with DAC.
Product Details
- Compounds: CJC-1295 No DAC (Mod GRF 1-29) + Ipamorelin
- Purity: >98% (HPLC verified), ADS included
- Form: Lyophilized powder
- Storage: Store at -20°C; after reconstitution, refrigerate at 2–8°C.
Why Buy CJC-1295 No DAC + Ipamorelin From MyGLP1Store
Veteran-owned, U.S.-based supplier. Third-party lab tested with a published Analytical Data Sheet (ADS), documented purity, and same-day domestic shipping. Verified Trustpilot 4.8.
CJC No DAC + Ipamorelin — Frequently Asked Questions
What is CJC-1295 No DAC?
CJC-1295 No DAC (Modified GRF 1-29) is a short-acting GHRH analog studied for its role in stimulating pulsatile growth hormone release. Without the DAC modification it has a shorter half-life than CJC-1295 with DAC, which researchers use to model more natural GH pulses.
Why is CJC-1295 No DAC combined with Ipamorelin?
CJC-1295 No DAC (a GHRH analog) and Ipamorelin (a selective ghrelin-receptor secretagogue) act on two complementary pathways. Studied together, they form the classic GHRH + GHRP model used to investigate synergistic, pulsatile GH release in laboratory settings.
Is the CJC No DAC + Ipamorelin blend third-party tested?
Yes. Each batch is HPLC-verified to >98% purity and ships with a published Analytical Data Sheet (ADS).
Research References
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561. PubMed
- Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799–805. PubMed
- Ionescu M, Frohman LA. Pulsatile secretion of GH persists during continuous stimulation by CJC-1295, a long-acting GHRH analog. J Clin Endocrinol Metab. 2006;91(12):4792–4797. PubMed
For laboratory and research use only. Not for human or veterinary consumption. Nothing here is medical advice or a dosing recommendation.





Reviews
There are no reviews yet.